Music |
Video |
Movies |
Chart |
Show |
The problem with recent kidney cancer trials |. JAMA Network Open | Use of Second-line Immunotherapy (Vinay Prasad MD MPH) View | |
Kidney Cancer Immunotherapy: Reasons for Cautious Optimism (GRACE - Global Resource for Advancing Cancer Education) View | |
ASCO 2021 renal roundup (ecancer) View | |
Factors in Selecting Immunotherapy or TKI Inhibition (OncLive) View | |
Second Line Therapy – What Comes Next Matt Milowsky, M.D. (Kidney Cancer) View | |
Dr Santosh Kumar C | 2nd Line options in Renal Cell Cancer (CRSF - Cancer Research and Statistic Foundation) View | |
Evaluating I-O Monotherapy’s Value in Treating mRCC (OncLive) View | |
SCAN FYI Oct 2, 2024: Immunotherapy -- One of the Latest Treatments for Cancer (SCAN NJ TV Shows) View | |
Highlighting Clinical Trials: Advanced/Metastatic Bladder Cancer | Part I (Bladder Cancer Advocacy Network) View | |
Systemic mRCC Treatment (Kidney Cancer) View |